Infographic | July 14, 2021

The Decentralized Clinical Trials Continuum

Why Decentralized Trials? Why Now?

The clinical trial landscape is continually adapting its focus on patient-centric practices to improve clinical trial participation by reducing patients’ burden. Over the past few years, this shift has focused on the idea of bringing the clinical trial to the patient’s home, a clear disruption of trial conduct today. Adoption has not been widespread; however, the COVID-19 pandemic shifted the need to quickly adopt this change.

What Are Decentralized Trials?

Everyone refers to and defines decentralized trials differently because we can virtualize many aspects of clinical trials. So, at what point is a trial considered “decentralized”?

At Veristat, a decentralized trial eases patients’ burden by delivering the clinical trial directly to them. Specifically, patient interactions take place remotely in the home, or through a hybrid combination of visits held at home, on site, or at community testing centers.

VIEW THE INFOGRAPHIC!

Get unlimited access to:

Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue. X

Enter your credentials below to log in. Not yet a member of Clinical Leader? Subscribe today.

Subscribe to Clinical Leader X

Please enter your email address and create a password to access the full content, Or log in to your account to continue.

or

Subscribe to Clinical Leader